InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-17.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Longitude Capital Partners IV, LLC. Officer active across 2 companies, notably Vera Therapeutics, Inc.. In total, 4 filings have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €15.5m. Activity tracked since 10 February 2022. The latest transaction was disclosed on 6 February 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Longitude Capital Partners IV, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
1,793,429 sharesCommon StockSEC:0001209191-23-054904:0
1,714,285 shares@ US$7.0071.8% of flowClass A Common StockSEC:0000899243-23-004349:0
Canonical exit: 7 May 2023 (T+90)
333,333 shares@ US$15.000.12% mcap100.0% of flowClass A Common StockSEC:0000899243-22-013598:0
Canonical exit: 11 May 2022 (T+90)
2,187,504 sharesClass A Common StockSEC:0001209191-21-033816:0
4 of 4 declarations
About Longitude Capital Partners IV, LLC
Longitude Capital Partners IV, LLC is a declarant linked to Vera Therapeutics, Inc. and Lexeo Therapeutics, Inc. No primary role is specified. The declarant has made 5 filings in total, and across the 5 most recent filings tracked here, purchases total 15498212 EUR with no sales, over the period from 2021-05-18 to 2023-11-09.
